Literature DB >> 12480810

Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy.

Ichiro Manabe1, Takayuki Shindo, Ryozo Nagai.   

Abstract

Structural remodeling of the ventricular wall is a key determinant of clinical outcome in heart disease. Such remodeling involves the production and destruction of extracellular matrix proteins, cell proliferation and migration, and apoptotic and necrotic cell death. Cardiac fibroblasts are crucially involved in these processes, producing growth factors and cytokines that act as autocrine and paracrine factors, as well as extracellular matrix proteins and proteinases. Recent studies have shown that the interactions between cardiac fibroblasts and cardiomyocytes are essential for the progression of cardiac remodeling. This review addresses the functional role played by cardiac fibroblasts and the molecular mechanisms that govern their activity during cardiac hypertrophy and remodeling. A particular focus is the recent progress toward our understanding of the transcriptional regulatory mechanisms involved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12480810     DOI: 10.1161/01.res.0000046452.67724.b8

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  167 in total

1.  Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy.

Authors:  Tetsuo Konno; Dan Chen; Libin Wang; Hiroko Wakimoto; Polakit Teekakirikul; Matthew Nayor; Masataka Kawana; Seda Eminaga; Joshua M Gorham; Kumar Pandya; Oliver Smithies; Francisco J Naya; Eric N Olson; J G Seidman; Christine E Seidman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-05       Impact factor: 11.205

2.  A novel phenylpyridazinone, T-3999, reduces the progression of autoimmune myocarditis to dilated cardiomyopathy.

Authors:  Fadia Ali Kamal; Kenichi Watanabe; Meilei Ma; Yuichi Abe; Reyad Elbarbary; Makoto Kodama; Yoshifusa Aizawa
Journal:  Heart Vessels       Date:  2010-10-05       Impact factor: 2.037

3.  c-Myc is required for proper coronary vascular formation via cell- and gene-specific signaling.

Authors:  Colby A Souders; Stephanie L K Bowers; Indroneal Banerjee; John W Fuseler; Jennifer L Demieville; Troy A Baudino
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03-08       Impact factor: 8.311

Review 4.  Fetal hypoxia and programming of matrix metalloproteinases.

Authors:  Wenni Tong; Lubo Zhang
Journal:  Drug Discov Today       Date:  2011-09-18       Impact factor: 7.851

5.  Genetic Analysis of Connective Tissue Growth Factor as an Effector of Transforming Growth Factor β Signaling and Cardiac Remodeling.

Authors:  Federica Accornero; Jop H van Berlo; Robert N Correll; John W Elrod; Michelle A Sargent; Allen York; Joseph E Rabinowitz; Andrew Leask; Jeffery D Molkentin
Journal:  Mol Cell Biol       Date:  2015-04-13       Impact factor: 4.272

6.  Smad3 and Bmal1 regulate p21 and S100A4 expression in myocardial stromal fibroblasts via TNF-α.

Authors:  Fuyuki Sato; Akira Kohsaka; Kana Takahashi; Saki Otao; Yusuke Kitada; Yoshiyuki Iwasaki; Yasuteru Muragaki
Journal:  Histochem Cell Biol       Date:  2017-07-18       Impact factor: 4.304

7.  Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart.

Authors:  DeLisa Fairweather; Sylvia Frisancho-Kiss; Susy A Yusung; Masheka A Barrett; Sarah E Davis; Shannon J L Gatewood; Dolores B Njoku; Noel R Rose
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

8.  IL-6 loss causes ventricular dysfunction, fibrosis, reduced capillary density, and dramatically alters the cell populations of the developing and adult heart.

Authors:  Indroneal Banerjee; John W Fuseler; Arti R Intwala; Troy A Baudino
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-20       Impact factor: 4.733

Review 9.  Cardiac fibroblasts : Active players in (atrial) electrophysiology?

Authors:  Alexander Klesen; Dorothee Jakob; Ramona Emig; Peter Kohl; Ursula Ravens; Rémi Peyronnet
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-02-01

10.  Cardiac steatosis potentiates angiotensin II effects in the heart.

Authors:  Denis J Glenn; Michelle C Cardema; Wei Ni; Yan Zhang; Yerem Yeghiazarians; Dmitry Grapov; Oliver Fiehn; David G Gardner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-05       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.